Is Roche (Roche) a good stock to buy?
The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. Roche has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.
What are analysts'1 year price targets for Roche's stock?
11 equities research analysts have issued 1 year price objectives for Roche's stock. Their forecasts range from $46.42 to $46.42. On average, they expect Roche's share price to reach $46.42 in the next twelve months. This suggests that the stock has a possible downside of 9.2%.
What does a hold rating on Roche's stock mean?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares. View analyst ratings for Roche or view top-rated stocks. How has Roche's stock price been impacted by Coronavirus?
Is there any short interest in Roche?
As of November 15th, there was short interest totaling 1,763,800 shares, an increase of 58.4% from the October 31st total of 1,113,300 shares. Based on an average daily volume of 1,491,300 shares, the short-interest ratio is currently 1.2 days. View Roche's Short Interest. How often does Roche pay dividends? What is the dividend yield for Roche?
See more
Is Roche a good stock to buy?
Roche has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.
Is Roche public?
Swiss pharmaceutical company Roche Holding is in 19th position of Morgan Stanley Capital International Perspective's annual ranking of the world's 100 largest public companies based on the companies' market value.
Why is Roche stock dropping?
Roche's pharmaceuticals business was primarily impacted by a large 30% drop in combined sales of Avastin, Herceptin, and Rituxan, as biosimilars from other companies gained market share.
Is Roche a dividend stock?
Roche pays a dividend 1 times a year. The payment month is March. The dividend calendar shows you for more than 1,000 dividend stocks in which month which company distributes its dividends.
How do I buy Roche stock in the US?
The Roche ADRs trade, clear and settle just like any U.S.-listed company shares and can be bought or sold through any U.S. registered brokerage (including online brokerages such as TD Ameritrade, E-Trade, Scottrade, etc.). Roche ADR holders are entitled to dividend payments.
What is the price of Roche stock?
SW) Stock Price, News, Quote & History - Yahoo Finance....Performance Outlook.Previous Close306.3052 Week Range298.30 - 404.20Volume1,728,872Avg. Volume1,396,9414 more rows
Why is Roche stock up?
Roche's revenue grew 13% y-o-y to $72.4 billion in 2021, aided by Covid-19 diagnostics tests and Ronapreve - a treatment for Covid-19, developed by Regeneron and distributed by Roche outside the U.S. The Covid-19 related products alone accounted for $7 billion of the $72 billion in sales for Roche in 2021.
What is Genentech stock price?
Stock market history ROCHE HOLDING (GENENTECH)XPriceMay 20, 2022319.7May 19, 2022316.9May 18, 2022321.25May 17, 2022322.35218 more rows
How much dividend does Roche pay?
RHHBY's annual dividend yield is 1.84%. When is Roche Holding ex-dividend date? Roche Holding's previous ex-dividend date was on Mar 16, 2022.
Should I buy or sell Roche stock right now?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 sell rating, 7 hold ratings...
What is Roche's stock price forecast for 2022?
12 brokerages have issued 1 year target prices for Roche's shares. Their forecasts range from $350.00 to $450.00. On average, they predict Roche's...
How has Roche's stock performed in 2022?
Roche's stock was trading at $51.69 at the start of the year. Since then, RHHBY stock has decreased by 23.4% and is now trading at $39.58. View th...
Are investors shorting Roche?
Roche saw a decline in short interest in May. As of May 31st, there was short interest totaling 1,381,500 shares, a decline of 36.3% from the May 1...
How often does Roche pay dividends? What is the dividend yield for Roche?
Roche announced a dividend on Tuesday, March 15th. Stockholders of record on Friday, March 18th will be given a dividend of $0.7922 per share on Mo...
Is Roche a good dividend stock?
Roche(OTCMKTS:RHHBY) pays an annual dividend of $0.78 per share and currently has a dividend yield of 1.96%. View Roche's dividend history .
Who are Roche's key executives?
Roche's management team includes the following people: Dr. Severin Schwan Ph.D. , CEO & Exec. Director (Age 55, Pay $7.81M) Dr. Alan Hippe , Ch...
Who are some of Roche's key competitors?
Some companies that are related to Roche include Johnson & Johnson (JNJ) , Eli Lilly and (LLY) , Pfizer (PFE) , AbbVie (ABBV) , Merck & Co., I...
What is Roche's stock symbol?
Roche trades on the OTCMKTS under the ticker symbol "RHHBY."
What is Roche stock worth in 2020?
What is Roche Holding AG?
Roche's stock was trading at $40.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RHHBY shares have increased by 14.3% and is now trading at $46.76. View which stocks have been most impacted by COVID-19.
What is a Roche valuation?
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Where is Roche located?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
Is Roche a member of the European Federation of Pharmaceutical Industries and Associations?
Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world, and the leading provider of cancer treatments globally.
What is a Roche valuation?
Roche is one of the few companies increasing their dividend every year, for 2018 as the 32nd consecutive year. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations.
Where is Roche located?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
Is Roche a member of the European Federation of Pharmaceutical Industries and Associations?
Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world, and the leading provider of cancer treatments globally.
2.4 Analyst's Opinion
Roche is one of the few companies increasing their dividend every year, for 2018 as the 32nd consecutive year. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations.
Is Roche a buy right now?
Roche has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.
How has Roche's stock been impacted by Coronavirus (COVID-19)?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Roche stock. View analyst ratings for Roche or view top-rated stocks.
Are investors shorting Roche?
Roche's stock was trading at $318.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, RHHVF shares have increased by 13.1% and is now trading at $360.70. View which stocks have been most impacted by COVID-19.
What price target have analysts set for RHHVF?
Roche saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 371,900 shares, an increase of 53.9% from the December 31st total of 241,700 shares. Based on an average trading volume of 4,300 shares, the days-to-cover ratio is currently 86.5 days. View Roche's Short Interest.
Who are some of Roche's key competitors?
8 brokers have issued 12-month price objectives for Roche's stock. Their forecasts range from $422.00 to $422.00. On average, they anticipate Roche's stock price to reach $422.00 in the next twelve months.
How do I buy shares of Roche?
Some companies that are related to Roche include Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MAYNF), Mayne Pharma Group (MYX), Medical Developments International (MVP), Opthea (OPT), Otsuka (OTSKY), Patrys (PAB), Pharmaxis (PXS), Recce Pharmaceuticals (RCE), Sanofi (SNYNF), Sanofi (SAN), Sinclair Pharma (SPH) and Vita Life Sciences (VLS). View all of RHHVF's competitors..